Novel Coronavirus (SARS-CoV-2/COVID-19)
      
		    Cody Regional Health in Wyoming created a wellness pod for hardworking staff. 
  
  The AHA has developed a new resource, “COVID-19 Models: Forecasting the Pandemic’s Spread,” in response to members’ interest in tools that can help them make decisions that are consistent with their organizations’ values and community needs. The report provides an overview of and links to 11 models…  
  AHA statement on additional emergency funding for hospitals & health systems from AHA President and CEO Rick Pollack. 
  
  Leaders from the Senate, House and Administration are poised to discuss proposals for the next COVID-19 relief package to combat the pandemic.
It is urgent that you contact your senators and representative today and urge them to provide additional funding of at least $100 billion for hospitals and…  
  The Centers for Medicare & Medicaid Services April 10 issued a proposed rule to update hospice payment rates for fiscal year 2021. CMS proposes a 2.6% net increase to payments of $580 million, compared to FY 2020. 
  
  The AHA, joined by other organizations, urged the U.S. Supreme Court to review a 3rd Circuit Court of Appeals decision that gives private individuals “broad license” to bring meritless False Claims Act lawsuits against hospitals and other health care providers.  
  
  The Centers for Medicare & Medicaid Services April 10 issued a proposed rule for the inpatient psychiatric facility prospective payment system for fiscal year 2021. CMS proposes to increase IPF payments by a net 2.4%, equivalent to $100 million, in FY 2021. 
  
  The Centers for Medicare & Medicaid Services April 10 issued a proposed rule updating fiscal year 2021 payments for the skilled nursing facilities prospective payment system. 
  
  The National Institutes of Health launched a study to determine how many adults in the U.S. without a confirmed COVID-19 history have antibodies to the virus. 
  
  The American Medical Association released two Current Procedural Terminology codes (86328 and 86769) for reporting antibody testing for the novel coronavirus, and revised its CPT code for SARS-CoV-2 nucleic acid tests (86318).